SCHEDULE 13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

March 20, 2001

Accession Number

0000891836-01-000086

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →